EVOKE PHARMA, INC. Proceeds from Warrant Exercises
EVOKE PHARMA, INC. reported Proceeds from Warrant Exercises of $3.58 million for the 12-month period ending 2024-12-31, per its 10-K filed 2025-03-13.
Financial Statements › Cash Flow › Financing Activities
us-gaap:ProceedsFromWarrantExercises · last filed 2025-11-13
- EVOKE PHARMA, INC. proceeds from warrant exercises for the quarter ending 2024-12-31 was $3.58M.
- EVOKE PHARMA, INC. proceeds from warrant exercises for the quarter ending 2024-09-30 was -$1.55M.
- EVOKE PHARMA, INC. proceeds from warrant exercises for the quarter ending 2024-06-30 was $295.70K.
- EVOKE PHARMA, INC. proceeds from warrant exercises for the quarter ending 2024-03-31 was $1.25M.
- EVOKE PHARMA, INC. proceeds from warrant exercises for fiscal 2024 was $3.58M.
| Period end | Proceeds from Warrant Exercises 1 month | Proceeds from Warrant Exercises 3 month | Proceeds from Warrant Exercises 6 month | Proceeds from Warrant Exercises 9 month | Proceeds from Warrant Exercises 12 month |
|---|---|---|---|---|---|
| 2024-12-31 | $3.58M derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-13 | $2.04M derived: sum of 2 quarters · filed 2025-11-13 | $2.33M derived: sum of 3 quarters · filed 2025-11-13 | $3.58M 10-K · filed 2025-03-13 | |
| 2024-10-31 | $3.60M 10-K · filed 2025-03-13 | ||||
| 2024-09-30 | -$1.55M derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-13 | -$1.25M derived: sum of 2 quarters · filed 2025-11-13 | $101.00 10-Q · filed 2025-11-13 | ||
| 2024-06-30 | $295.70K derived: 10-Q 6 month − 10-Q 3 month · filed 2025-08-14 | $1.55M 10-Q · filed 2025-08-14 | |||
| 2024-03-31 | $1.25M 10-Q · filed 2024-05-14 |